Sage Journals: Discover world-class research

Abstract

Frailty, reflecting diminished physiological reserve, may influence how Alzheimer's disease (AD) pathology manifests. This study evaluated the prognostic relevance of frailty in mild cognitive impairment due to AD (MCI-AD). 50 patients underwent frailty assessment using the Clinical Frailty Scale (CFS), with multimorbidity, polypharmacy, and cognition (Mini-Mental State Examination, MMSE) recorded. Participants (median age 74 years; 76% women) exhibited low frailty (median CFS 3). Higher CFS scores correlated with lower baseline MMSE and faster annual decline. In adjusted analyses, CFS independently predicted both poorer cognition and steeper decline, whereas CSF P-tau did not. Frailty thus provides complementary prognostic information to biomarkers in the early stages of AD.

Keywords

Alzheimer's disease clinical frailty scale cognitive decline cognitive impairment early AD

Get full access to this article

View all access options for this article.

References

Wallace

LMK

Theou

Godin

, et al. Investigation of frailty as a moderator of the relationship between neuropathology and dementia in Alzheimer’s disease: a cross-sectional analysis of data from the rush memory and aging project. Lancet Neurol 2019; 18: 177–184.

Canevelli

Arisi

Bacigalupo

, et al. Biomarkers and phenotypic expression in Alzheimer’s disease: exploring the contribution of frailty in the Alzheimer’s disease neuroimaging initiative. Geroscience 2021; 43: 1039–1051.

Trebbastoni

Canevelli

D’Antonio

, et al. The impact of frailty on the risk of conversion from mild cognitive impairment to Alzheimer’s disease: evidences from a 5-year observational study. Front Med (Lausanne) 2017; 4: 178.

Ward

Wallace

LMK

Rockwood

. Frailty and risk of dementia in mild cognitive impairment subtypes. Ann Neurol 2021; 89: 1221–1225.

Rockwood

Song

MacKnight

, et al. A global clinical measure of fitness and frailty in elderly people. CMAJ 2005; 173: 489–495.

American Psychiatric Association. Diagnostic and statistical manual of mental disorders: DSM-5. 5th ed. Washington, D.C.: American Psychiatric Association, 2013.

Lawton

Brody

. Assessment of older people: self-maintaining and instrumental activities of daily living. Gerontologist 1969; 9: 179–186.

Massa

Halbgebauer

Barba

, et al. Exploring the brain metabolic correlates of process-specific CSF biomarkers in patients with MCI due to Alzheimer’s disease: preliminary data. Neurobiol Aging 2022; 117: 212–221.

Hansson

Batrla

Brix

, et al. The Alzheimer’s association international guidelines for handling of cerebrospinal fluid for routine clinical measurements of amyloid β and tau. Alzheimers Dement 2021; 17: 1575–1582.

10.

Folstein

McHugh

. Mini-mental state’. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12: 189–198.

11.

Linn

Gurel

. Cumulative illness rating scale. J Am Geriatr Soc 1968; 16: 622–626.

12.

Boustani

Campbell

Munger

, et al. Impact of anticholinergics on the aging brain: a review and practical application. Aging Health 2008; 4: 311–320.

13.

Rockwood

Theou

. Using the clinical frailty scale in allocating scarce health care resources. Can Geri J 2020; 23: 254–259.

14.

Benussi

Mattioli

Silvestri

, et al. Defining the role of frailty in the transition from mild cognitive impairment to dementia and in dementia progression. Dement Geriatr Cogn Disord 2024; 53: 57–65.

15.

Buscarnera

Canevelli

Bruno

, et al. Unraveling the link between frailty and Alzheimer’s disease biomarkers in patients with mild cognitive impairment. Geroscience 2025; 47: 5985–5994.

Frailty in early Alzheimer's disease: Complementary clinical value and prognostic significance in biomarker-defined mild cognitive impairment due to Alzheimer's disease

Abstract

Keywords

Get full access to this article

References